By Jonathan Capriel (October 23, 2025, 6:25 p.m. EDT) — The U.S. Securities and Exchange Commission “unintentionally” sided with a former partner with a terminated licensing agreement, a pharmaceutical CEO told a California federal court this week, seeking summary judgment on the SEC's main allegations that he defrauded investors.
Law360 is there, so you are too.
A Law360 subscription puts you at the center of rapidly evolving legal issues, trends and developments so you can act with speed and confidence. More than 200 articles are published daily on more than 60 topics, sectors, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge Information
- Real-time alerts
- More than 450,000 archived articles available for consultation
And much more!
Check out Law360 today with a 7-day free trial.
